Search Within

Paul K Paik

Formats
  1. Meeting Abstract (168)
  2. Journal Article (83)
  3. Review (4)
  4. Book Section (1)
Groups
  1. Department of Medicine (256)
  2. Solid Tumor Oncology Division (256)
  3. Thoracic Oncology (256)
  4. GSK Faculty (77)
  5. Department of Pathology and Laboratory Medicine (74)
  6. Human Oncology and Pathogenesis Program (55)

More Groups

People
  1. Mark Kris (55)
  2. Marc Ladanyi (47)
  3. Gregory Riely (42)
  4. Natasha Rekhtman (41)
  5. Charles Rudin (40)
  6. Jamie Chaft (33)

More People

Years
  1. 2025 (6)
  2. 2024 (15)
  3. 2023 (32)
  4. 2022 (39)
  5. 2021 (34)
  6. 2020 (18)

More Years

Publications
  1. Journal of Thoracic Oncology (60)
  2. Journal of Clinical Oncology (49)
  3. Annals of Oncology (34)
  4. Clinical Cancer Research (12)
  5. International Journal of Radiation Oncology, Biology, Physics (11)
  6. Clinical Lung Cancer (6)

More Publications

Publishers
  1. Elsevier Inc. (81)
  2. American Society of Clinical Oncology (56)
  3. Oxford University Press (38)
  4. American Association for Cancer Research (22)
  5. Wiley Blackwell (12)
  6. Nature Publishing Group (11)

More Publishers

Results (256)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prevalence, clinicopathologic associations, and molecular spectrum of ERBB2 (HER2) tyrosine kinase mutations in lung adenocarcinomas
    Journal Article

    Arcila, M. E.; Chaft, J. E.; Nafa, K.; Roy Chowdhuri, S.; Lau, C.; Zaidinski, M.; Paik, P. K.; Zakowski, M. F.; Kris, M. G.; Ladanyi, M.
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • Resolving the controversy on EGFR/KRAS mutations in pulmonary squamous cell carcinoma via comprehensive pathologic assessment incorporating immunohistochemistry
    Meeting Abstract

    Rekhtman, N.; Paik, P. K.; Arcila, M. E.; Tafe, L. J.; Oxnard, G. R.; Moreira, A. L.; William, T. D.; Zakowski, M. F.; Mark, K. G.; Ladanyi, M.
    Modern Pathology (2012)

    Fulltext@MSK | Save
  • Resolving the controversy on EGFR/KRAS mutations in pulmonary squamous cell carcinoma via comprehensive pathologic assessment incorporating immunohistochemistry
    Meeting Abstract

    Rekhtman, N.; Paik, P. K.; Arcila, M. E.; Tafe, L. J.; Oxnard, G. R.; Moreira, A. L.; William, T. D.; Zakowski, M. F.; Mark, K. G.; Ladanyi, M.
    Laboratory Investigation (2012)

    Fulltext@MSK | Save
  • Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: Lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations
    Journal Article

    Rekhtman, N.; Paik, P. K.; Arcila, M. E.; Tafe, L. J.; Oxnard, G. R.; Moreira, A. L.; Travis, W. D.; Zakowski, M. F.; Kris, M. G.; Ladanyi, M.
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • Coexistence of PIK3CA and other oncogene mutations in lung adenocarcinoma-rationale for comprehensive mutation profiling
    Journal Article

    Chaft, J. E.; Arcila, M. E.; Paik, P. K.; Lau, C.; Riely, G. J.; Pietanza, M. C.; Zakowski, M. F.; Rusch, V.; Sima, C. S.; Ladanyi, M.; more...
    Molecular Cancer Therapeutics (2012)

    Fulltext@MSK | Save
  • Response to EGFR TKIs in never smokers with stage IV EGFR mutant squamous cell carcinoma of the lung (SQCC)
    Meeting Abstract

    Paik, P. K.; Rekhtman, N.; Riely, G. J.; Miller, V. A.; Ladanyi, M.; Kris, M. G.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer
    Journal Article

    Paik, P. K.; Rudin, C. M.; Pietanza, M. C.; Brown, A.; Rizvi, N. A.; Takebe, N.; Travis, W.; James, L.; Ginsberg, M. S.; Juergens, R.; more...
    Lung Cancer (2011)

    Fulltext@MSK | Save
  • A phase 2 study of weekly albumin-bound paclitaxel (Abraxane ®) given as a two-hour infusion
    Journal Article

    Paik, P. K.; James, L. P.; Riely, G. J.; Azzoli, C. G.; Miller, V. A.; Ng, K. K.; Sima, C. S.; Heelan, R. T.; Kris, M. G.; Moore, E.; more...
    Cancer Chemotherapy and Pharmacology (2011)

    Fulltext@MSK | Save
  • Testing epidermal growth factor receptor mutations in patients with non-small-cell lung cancer to choose chemotherapy: The other side of the coin - Reply
    Journal Article

    Paik, P. K.; D'Angelo, S.; Kris, M. G.; Riely, G. J.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • A window study evaluating the activity of single agent bevacizumab prior to induction chemotherapy for operable non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Paik, P. K.; Oxnard, G. R.; Price, K.; Sima, C. S.; Ginsberg, M. S.; Travis, W. D.; Rusch, V.; Kris, M. G.; Rizvi, N. A.
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save